白血病靶向治疗新进展
摘要
目的针对白血病细胞增殖、生存的某些环节的靶向治疗是目前白血病治疗研究的一个重要课题。本文对以下内容进行了综述(1)单克隆抗体的靶向治疗;(2)融合基因的靶向治疗;(3)凋亡调节因子的靶向治疗;(4)STAT信号转导途径的靶向治疗;(5)DNA甲基化靶向治疗;(6)细胞因子-受体介导的靶向治疗。
出处
《临床军医杂志》
CAS
2006年第6期740-742,共3页
Clinical Journal of Medical Officers
参考文献17
-
1Haiusworth J D.Monocloa al antibody therapy in lymphoid malignancies[ J ].Oncologist,2000,5 (5):376.
-
2Press O W,Leonard J P,Coiffier B,et al.Immunothetapy of nonhodgkin's lymphomes[ J].Hemotology,2001,(1):221.
-
3Thomas C,Foulet A,Plat M,et al.Eficacy of rituximab in lymphomatoid granulomatesis[ J ].Rev Mal Respir,2004,21 (6):1157.
-
4Felcman E,Kalaycli M,Wwimer G,et al.Treatment of relapsed or refractory acute myeloid leukemia with humanized anti-CD33monoclonal antibody HuMI95[ J ].Leukemia,2003,17 (2):314 -318.
-
5Sievera E L,Larson R A,Stadtmauer E A,et al.Efi-cacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukenfia in first relapse[ J].J Clin Onco1,2001,19(13):3244 -3254.
-
6Larson R A,Boogae I'S M,Esfey E,et al.Antibody targeted chemotherapy of older patients with acute myeloid leukemia in first reIapse using mylotarg(gemtuzumab ozogamicin)[ J ].Eukemia,2002,16 (9):1627-1636.
-
7Picaluda P P,Martinei I T G,Rondonun M,et al.Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas[ J ].Leuk Lymphoma,2004,45 (9):1791-1795.
-
8Osterborg A,D r M J,Bunjes D,et al.Phase Ⅱ muhicencer study of human CD52 antibody in previously therapy chronic lymphocytic leukemia[ J ].J Clin Oneol,1997,15 (4):1567.
-
9Druker B J.Imatinib and chronic myeloid leukemia:validating the promise of molecularly targeted therapy[ J ].Cancer,2002,38(suppl 5):570 -576.
-
10Pateraon S C,Smith K D,Holyoake T L.Is there a cloud in the silver lining for imatinib[ J ].Cancer,2003,88 (7):983-987.
二级参考文献27
-
1Mitsiades N, Mitsiades C S, Poulaki A V, et al. Bioligic sequelae of nuclear factor-KB blockade in multipla myeloma therapeutic application[J]. Blood, 2002,99( 11 ): 4079-4086.
-
2Tran J, Rak J ,Sheehan C, et al . Marked induction of the IAP family antiapptotic proteins survivin and XIAP by VEGF in vascular endothelial cells [J]. Biochem Biophys Res Comm,1999,264(3) :781-788.
-
3Kini A R,Peterson L C,Tallman M S, et al . Angiogenesis in acute promyelocytic leukemia., induction by vascular erdothelial growth factor and inhibition by all-trans retinoic acid[J]. Blood,2001,97(12) :3919-3924.
-
4Dias S,Shmelkov S V,Lam G, et al . VEGF (165) promotes survival of leukemia cells by Hsp 90 mediated induction of bcl-2 expression and apoptosis inhibition [J]. Blood, 2002,99 ( 7 ) :2532-2540.
-
5Dias S,Choy M,Alitalo K, et al . Vascular endothelial growth factor ( VEGF )-csignaling through FLT-4 ( VEGFR-3 )mediates leukemia cell proliferation, survival and resistance to chemotheraoy[J]. Blood,2002,99(6) :2179-2184.
-
6Leppilampi M, Koitinen P. Savolainer E R, et al. The expression of carbonic anhydrase Ⅱ in hematological malignancies[J]. Clin Cancer Res,2002,8(7) :2240-2245.
-
7Gilliland D G,Griffin J D. The role of FLT3: hematopoiesis and leukemia[J]. Blood,2002,100(5) :1532-1542.
-
8Buettner R, Mora L B, Jove R. Activated STAT signaling in human tumours provides novel molecular targets for therapeutic intervention[J]. Clin Cancer Res, 2002,8 (4) : 945-954.
-
9Cohen M H, Williams G, Johnson J R, et al. Approved summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia [ J ]. Clin Cancer Res, 2002, 8(5) : 935-942.
-
10O'Dwyer M E, Mauro M J, Kurilik G, at al. The impact of clinical evolution on response to imatinib mesylate (STI 571)in accelerated phase CML[J]. Blood,2002,100(5) :1628-1633.
-
1杨正国.Fas、Fas配体与系统性红斑狼疮[J].肾脏病与透析肾移植杂志,1997,6(6):561-564.
-
2王艳勋,李振华.细胞因子网络与特发性肺纤维化[J].国际呼吸杂志,2010,30(16):997-1001. 被引量：8
-
3李雨真,朱栋栋,李洁,宋业琳.补肾活血汤对慢性心力衰竭大鼠血清sFas、MMP-2的影响[J].世界中西医结合杂志,2012,7(5):394-396. 被引量：10
-
4江浩.慢性粒细胞白血病靶向治疗中分子学监测的意义[J].中国实用内科杂志,2008,28(12):1015-1017.
-
5何玉婵,王晓桃.靶向干预骨髓微环境治疗急性淋巴细胞白血病的研究进展[J].医学综述,2015,21(8):1364-1367. 被引量：2
-
6赵晖,戚秀卿,邓南伟.sFas及sFas-L与慢性心力衰竭[J].同济大学学报（医学版）,2002,23(5):394-396.
-
7陈竺当选法国科学院外籍院士[J].上海第二医科大学学报,2005,25(9):876-876.
-
8系统性红斑狼疮研究荟萃[J].中华医学信息导报,2008,23(9):7-7.
-
9SeidelN.,Volkmann X.,Lnger F.,K. Schulze-Osthoff,王志宇.血清中半胱天冬氨酸蛋白酶活性可反映慢性丙型肝炎病毒感染肝脂肪化程度[J].世界核心医学期刊文摘（胃肠病学分册）,2005,0(10):42-42.
-
10翁立坚,林若玲,黄健美,蔡若吟.格拉诺赛特治疗急性淋巴细胞白血病化疗后白细胞减少症的疗效分析[J].临床医学,2004,24(7):2-3.
